{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:21:14Z","timestamp":1790968874385,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","award":["U10-DA13043"],"award-info":[{"award-number":["U10-DA13043"]}],"id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007880","name":"Johns Hopkins University","doi-asserted-by":"publisher","award":["KO5 DA-17009"],"award-info":[{"award-number":["KO5 DA-17009"]}],"id":[{"id":"10.13039\/100007880","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K12-DA000357"],"award-info":[{"award-number":["K12-DA000357"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U10-DA020024"],"award-info":[{"award-number":["U10-DA020024"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.addbeh.2012.04.011","type":"journal-article","created":{"date-parts":[[2012,5,8]],"date-time":"2012-05-08T04:30:57Z","timestamp":1336451457000},"page":"1046-1053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Predictors of attrition with buprenorphine\/naloxone treatment in opioid dependent youth"],"prefix":"10.1016","volume":"37","author":[{"given":"Diane","family":"Warden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha A.","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Carmody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E.","family":"Woody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu","family":"Minhajuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina A.","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bogenschutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Patkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhukar H.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addbeh.2012.04.011_bb0005","series-title":"Manual for the youth self report and 1991 profile","author":"Achenbach","year":"1991"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0010","series-title":"Manual for the young adult self-report and 1997 profiles","author":"Achenbach","year":"1997"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.drugalcdep.2003.11.002","article-title":"Effectiveness of interventions on opiate withdrawal treatment: An overview of systematic reviews","volume":"73","author":"Amato","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jsat.2005.02.007","article-title":"An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research","volume":"28","author":"Amato","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0025","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1477-7517-7-29","article-title":"Opioid substitution therapy in Manipur and Nagaland, North-East India: Operational research in action","volume":"7","author":"Armstrong","year":"2010","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/09595230500537670","article-title":"Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: A file review","volume":"25","author":"Bell","year":"2006","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0376-8716(03)00071-1","article-title":"Cessation of methadone maintenance treatment using buprenorphine: Transfer from methadone to buprenorphine and subsequent buprenorphine reductions","volume":"71","author":"Breen","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0040","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1360-0443.2009.02633.x","article-title":"Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: Patient characteristics and patterns and predictors of treatment retention","volume":"104","author":"Burns","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/02791072.2004.10399726","article-title":"Clinical characteristics and treatment outcomes of adolescent heroin users","volume":"36","author":"Clemmey","year":"2004","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0050","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.drugalcdep.2005.10.020","article-title":"Abuse of prescription drugs and the risk of addiction","volume":"83S","author":"Compton","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11090","article-title":"Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation","volume":"11","author":"Connock","year":"2007","journal-title":"Health Technology Assessment"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ije\/22.2.273","article-title":"Risk factors for overdose mortality: A case\u2013control study within a cohort of intravenous drug users","volume":"22","author":"Davoli","year":"1993","journal-title":"International Journal of Epidemiology"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0275","author":"Drug Abuse Warning Network (DAWN)"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0070","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1046\/j.1360-0443.1999.94913376.x","article-title":"Buprenorphine versus methadone maintenance for the treatment of opioid dependence","volume":"94","author":"Fischer","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0075","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2105\/AJPH.86.5.655","article-title":"Viral infections in short-term injection drug users: The prevalence of hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses","volume":"86","author":"Garfein","year":"1996","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2003.11.017","article-title":"Buprenorphine versus methadone for opioid dependence: Predictor variables for treatment outcome","volume":"75","author":"Gerra","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0085","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0306-4603(90)90036-W","article-title":"The development of a Short Opiate Withdrawal Scale (SOWS)","volume":"15","author":"Gossop","year":"1990","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0280","first-page":"CD002025","article-title":"Buprenorphine for the management of opioid withdrawal","volume":"3","author":"Gowing","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0095","first-page":"1316","article-title":"Heroin use among adolescents in treatment for substance use disorders","volume":"39","author":"Hopfer","year":"2000","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0100","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpsyc.58.5.503","article-title":"A 33-year follow-up of narcotics addicts","volume":"58","author":"Hser","year":"2001","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0105","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0285","series-title":"Monitoring the future: National results on adolescent drug use: Overview of key findings, 2010","author":"Johnston","year":"2011"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0115","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","article-title":"1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: A randomized, placebo-controlled trial","volume":"22","author":"Kakko","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1037\/0893-164X.15.1.52","article-title":"Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment","volume":"15","author":"Kampman","year":"2001","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0290","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/00952990802585380","article-title":"Brief vs. extended buprenorphine detoxification in a community treatment program: Engagement and short-term outcomes","volume":"35","author":"Katz","year":"2009","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11606-008-0866-8","article-title":"Home buprenorphine\/naloxone induction in primary care","volume":"24","author":"Lee","year":"2008","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drugalcdep.2007.10.017","article-title":"Multi-centre observational study of buprenorphine use in 32 Italian drug addiction centres","volume":"94","author":"Leonardi","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0140","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jadohealth.2006.11.142","article-title":"Buprenorphine replacement therapy for adolescents with opioid dependence: Early experience from a children's hospital-based outpatient treatment program","volume":"40","author":"Levy","year":"2007","journal-title":"Journal of Adolescent Health"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0145","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archpsyc.62.10.1157","article-title":"Comparison of pharmacological treatments for opioid-dependent adolescents: A randomized controlled trial","volume":"62","author":"Marsch","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0376-8716(99)00110-6","article-title":"Concurrent and predictive validity of the Substance Dependence Severity Scale (SDSS)","volume":"59","author":"Miele","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0160","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1370\/afm.665","article-title":"Treating opioid addiction with buprenorphine\u2013naloxone in community-based primary care settings","volume":"5","author":"Mintzer","year":"2007","journal-title":"Annals of Family Medicine"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0165","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/ADM.0b013e31816b2f84","article-title":"Differences in treatment outcomes between prescription opioid-dependent and heroin-dependent adolescents","volume":"2","author":"Motamed","year":"2008","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0170","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1037\/0893-164X.9.4.242","article-title":"Reliability of self-reported HIV risk behaviors of drug users","volume":"9","author":"Needle","year":"1995","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0295","series-title":"Risk behavior survey","author":"NIDA","year":"1993"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(00)80006-X","article-title":"Buprenorphine: A controlled clinical trial in the treatment of opioid dependence","volume":"60","author":"Pani","year":"2000","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0180","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0190","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/630209","article-title":"Retention in opioid substitution treatment: A major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment","volume":"49","author":"Roux","year":"2009","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0195","first-page":"14","article-title":"Is premature termination of opiate detoxification due to intensive withdrawal or craving?","volume":"72","author":"Scherbaum","year":"2004","journal-title":"Fortschritte der Neurologie-Psychiatrie"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00005053-199801000-00006","article-title":"Prognostic factors in buprenorphine- versus methadone-maintained patients","volume":"186","author":"Schottenfeld","year":"1998","journal-title":"The Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0205","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/jama.283.10.1303","article-title":"Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: A randomized controlled trial","volume":"8","author":"Sees","year":"2000","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0210","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: Results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0215","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1525-1497.2005.0228.x","article-title":"Brief report: Buprenorphine retention in primary care","volume":"20","author":"Stein","year":"2005","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0220","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF02247469","article-title":"Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users","volume":"116","author":"Strain","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0225","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1176\/ajp.151.7.1025","article-title":"Comparison of buprenorphine and methadone in the treatment of opioid dependence","volume":"151","author":"Strain","year":"1994","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0230","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1360-0443.2009.02829.x","article-title":"The added risk of opioid problem use among treatment-seeking youth with marijuana and\/or alcohol problem use","volume":"105","author":"Subramaniam","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0300","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2008.10.015","article-title":"Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder","volume":"101","author":"Subramaniam","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0240","first-page":"1120","article-title":"Predictors of abstinence: NIDA multi-site buprenorphine\/naloxone treatment trial in opioid dependent youth","volume":"50","author":"Subramaniam","year":"2011","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0305","series-title":"Rockville, MD: National Admissions to Substance Abuse Treatment Services, DASIS Series: S-56, HHS Publication No. (SMA) 11\u20134646","author":"Substance Abuse and Mental Health Services Administration, Treatment Episode Data Set (TEDS). 1999\u20132009","year":"2011"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jsat.2006.03.007","article-title":"Multimodal drug addiction treatment: A field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients","volume":"31","author":"Vigezzi","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0255","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-3565(25)10510-7","article-title":"Acute administration of buprenorphine in humans\u2014Partial agonist and blockade effects","volume":"274","author":"Walsh","year":"1995","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0260","first-page":"2003","article-title":"Extended vs short-term buprenorphine\u2013naloxone for treatment of opioid-addicted youth","volume":"300","author":"Woody","year":"2008","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.addbeh.2012.04.011_bb0265","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.1360-0443.2003.00354.x","article-title":"Does retention matter? Treatment duration and improvement in drug use","volume":"98","author":"Zhang","year":"2003","journal-title":"Addiction"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460312001591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460312001591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:32:05Z","timestamp":1759689125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460312001591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0306460312001591"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2012.04.011","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of attrition with buprenorphine\/naloxone treatment in opioid dependent youth","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2012.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}